要点与陷阱:吡哆醇依赖性癫痫中对吡哆醇的延迟反应
吡哆醇依赖性癫痫(PDE)由ALDH7A1双等位基因致病变异引起,可表现为难治性新生儿惊厥和癫痫持续状态。本文报告一例足月新生儿PDE,静脉负荷吡哆醇后数小时惊厥停止,但EEG背景和临床脑病改善在5天后才出现,提示疑似病例应持续补充维生素B6直至基因确诊或发现其他病因。
要点
- PDE由ALDH7A1双等位基因致病变异引起,表现为难治性新生儿惊厥和癫痫持续状态。
- 静脉吡哆醇负荷后惊厥可数小时停止,但EEG背景和脑病改善可能延迟至5天。
- 疑似PDE病例应持续补充维生素B6直至基因确诊或发现其他病因。
核心结论
- PDE病例中临床改善可能逐渐出现并需持续治疗数天,疑似病例应持续补充维生素B6直至基因确诊或发现其他病因。
研究设计与样本
- 本文为病例报告,报告一例足月新生儿PDE。
主要发现
- 静脉吡哆醇负荷后数小时惊厥停止,但EEG背景和临床脑病水平改善在5天后出现。
临床怎么用
- 作者通过本例说明疑似PDE病例应持续补充维生素B6直至基因确诊或发现其他病因。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Inborn errors of metabolism are a diverse group of genetic disorders including many that cause neonatal-onset epilepsy such as pyridoxine-dependent epilepsy (PDE). PDE occurs secondary to biallelic pathogenic variants in ALDH7A1 and can present with refractory neonatal seizures and status epilepticus. Neonatal seizures and encephalopathy are modifiable with pyridoxine (vitamin B6) supplementation. However, the clinical response to pyridoxine supplementation can be delayed. We present the case of a full-term neonate with PDE in which seizure cessation was seen a few hours after intravenous pyridoxine load, but the improvement in EEG background and level of clinical encephalopathy occurred 5 days later. We share this case to provide an example in which clinical improvement in PDE was gradual and required continuation of treatment for several days illustrating the necessity of continuing vitamin B6 supplementation in suspected cases until confirmatory genetic testing is obtained or an alternate cause is found.
引用
- Fortin O, Christoffel K, Kousa Y, et al. Pearls & Oy-sters: Delayed Response to Pyridoxine in Pyridoxine-Dependent Epilepsy. Neurology. 2023. PMID: 37580162. doi:10.1212/WNL.0000000000207829
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。